Overview
Sponsor-declared trial summary
Phase
Therapeutic use (Phase IV)
Status
Authorised, recruitment pending
Participants planned
60
Countries
1
Sites
1
Chronic Obstructive Pulmonary Disease
Key facts
- Sponsor
- CHU Saint Pierre
- Participant type
- Patients
- Age range
- 18-64 years, 65+ years
- Gender
- Male and Female
- Therapeutic area
- Diseases [C] - Respiratory Tract Diseases [C08]
- Decision date (initial)
- 2026-01-19
- Transition trial
- No
- Low-intervention
- No
- Rare-disease indication
- No
- Vulnerable population
- No
Trial design
CTIS Part I — objectives, methods, condition coding
Conditions and MedDRA coding
Chronic Obstructive Pulmonary Disease
Sponsors and contacts
Sponsor organisations, regulatory contacts, third parties
CHU Saint Pierre
3
Total trials
Academic / Non-commercial
- Sponsor organisation
- CHU Saint Pierre
- Address
- Waterloolaan 129
- City
- Brussels
- Postcode
- 1000
- Country
- Belgium
Scientific contact point
- Organisation
- CHU Saint Pierre
- Contact name
- Study Coordinator
Public contact point
- Organisation
- CHU Saint Pierre
- Contact name
- Study Coordinator
Locations
1 EU/EEA country · 1 investigational sites
By country
| Country | MS status | Planned subjects | Sites |
|---|---|---|---|
| Belgium | Authorised, recruitment pending | 60 | 1 |
| Rest of world | — | 0 | — |
Investigational sites
Application history
1 submissions — initial application plus substantial / non-substantial modifications
| # | Type | Code | Submitted | Reference MS | Conclusion | Decision date |
|---|---|---|---|---|---|---|
| 1 | INITIAL | IN | 2025-10-15 | Belgium | Acceptable with conditions 2026-01-19
|
2026-01-19 |